0
Effects of ADHD, Conduct Disorder, and Gender on Substance Use and Abuse in Adolescence
Elizabeth R. Disney, B.A.; Irene J. Elkins, Ph.D.; Matt McGue, Ph.D.; William G. Iacono, Ph.D.
Concurrent and Predictive Validity of the Personality Disorder Diagnosis in Adolescent Inpatients
Kenneth N. Levy, M.A., M.Phil.; Daniel F. Becker, M.D.; Carlos M. Grilo, Ph.D.; Jonathan J.F. Mattanah, Ph.D.; Kathleen E. Garnet, Ph.D.; Donald M. Quinlan, Ph.D.; William S. Edell, Ph.D.; Thomas H. McGlashan, M.D.
Influence of Child and Adolescent Psychiatric Disorders on Young Adult Personality Disorder
Stephanie Kasen, Ph.D.; Patricia Cohen, Ph.D.; Andrew E. Skodol, M.D.; Jeffrey G. Johnson, Ph.D.; Judith S. Brook, Ed.D.
Children’s Symptoms in the Wake of Challenger: A Field Study of Distant-Traumatic Effects and an Outline of Related Conditions
Lenore C. Terr, M.D.; Daniel A. Bloch, Ph.D.; Beat A. Michel, M.D.; Hong Shi, M.S.; John A. Reinhardt, Ph.D.; SuzAnne Metayer
Panic Attacks and Suicide Attempts in Mid-Adolescence
Daniel J. Pilowsky, M.D., M.P.H.; Li-Tzy Wu, Sc.D.; James C. Anthony, Ph.D.
Affective Responsiveness in Borderline Personality Disorder: A Psychophysiological Approach
Sabine C. Herpertz, M.D.; Hanns J. Kunert, Ph.D.; Ulrich B. Schwenger, M.Eng.; Henning Sass, M.D.
Clinical and Neurobiological Correlates of Cytogenetic Abnormalities in Childhood-Onset Schizophrenia
Rob Nicolson, M.D.; Jay N. Giedd, M.D.; Marge Lenane, M.S.W.; Susan Hamburger, M.A., M.S.; Sujatha Singaracharlu, M.D.; Jeffrey Bedwell, B.S.; Tom Fernandez, A.B.; Gunvant K. Thaker, M.D.; Dolores Malaspina, M.D.; Judith L. Rapoport, M.D.
Lamina-Specific Alterations in the Dopamine Innervation of the Prefrontal Cortex in Schizophrenic Subjects
Mayada Akil, M.D.; Joseph N. Pierri, M.S., M.D.; Richard E. Whitehead, B.S.; Christine L. Edgar, B.S.; Carrie Mohila, B.S.; Allan R. Sampson, Ph.D.; David A. Lewis, M.D.
Suicidal Behavior in Patients With Schizophrenia and Other Psychotic Disorders
Elizabeth D. Radomsky, Ph.D.; Gretchen L. Haas, Ph.D.; J. John Mann, M.D.; John A. Sweeney, Ph.D.
Conjugal Loss and Syndromal Depression in a Sample of Elders Aged 70 Years or Older
Carolyn L. Turvey, Ph.D.; Caroline Carney, M.D.; Stephan Arndt, Ph.D.; Robert B. Wallace, M.D.; Regula Herzog, Ph.D.
White Matter Hyperintensities and Gray Matter Lesions in Physically Healthy Depressed Subjects
Eric Lenze, M.D.; DeWitte Cross, M.D.; Daniel McKeel, M.D.; Rosalind J. Neuman, Ph.D.; Yvette I. Sheline, M.D.
Treatment of Primary Dysthymia With Group Cognitive Therapy and Pharmacotherapy: Clinical Symptoms and Functional Impairments
Arun V. Ravindran, M.D., Ph.D.; Hymie Anisman, Ph.D.; Zul Merali, Ph.D.; Yoland Charbonneau, M.D.; John Telner, Ph.D.; Robert J. Bialik, Ph.D.; Andrew Wiens, M.D.; Jack Ellis, M.D.; Jenna Griffiths, Ph.D.
Cerebral Blood Flow Changes Associated With Attribution of Emotional Valence to Pleasant, Unpleasant, and Neutral Visual Stimuli in a PET Study of Normal Subjects
Sergio Paradiso, M.D., Ph.D.; Debra L. Johnson, Ph.D.; Nancy C. Andreasen, M.D., Ph.D.; Daniel S. O’Leary, Ph.D.; G. Leonard Watkins, Ph.D.; Laura L. Boles Ponto, Ph.D.; Richard D. Hichwa, Ph.D.
Enhancement of CO2-Induced Anxiety in Healthy Volunteers With the Serotonin Antagonist Metergoline
Itzhak Z. Ben-Zion, M.D.; Gal Meiri, M.D.; Benjamin D. Greenberg, M.D., Ph.D.; Dennis L. Murphy, M.D.; Jonathan Benjamin, M.D.
Compounds Containing Cytosolic Choline in the Basal Ganglia: A Potential Biological Marker of True Drug Response to Fluoxetine
Shamsah B. Sonawalla, M.D.; Perry F. Renshaw, M.D., Ph.D.; Constance M. Moore, M.Sc., Ph.D.; Jonathan E. Alpert, M.D., Ph.D.; Andrew A. Nierenberg, M.D.; Jerrold F. Rosenbaum, M.D.; Maurizio Fava, M.D.
Magnetic Resonance Assessment of Cerebral Perfusion in Depressed Cardiac Patients: Preliminary Findings
P. Murali Doraiswamy, M.D.; James MacFall, Ph.D.; K. Ranga R. Krishnan, M.D.; Christopher O’Connor, M.D.; Xin Wan, Ph.D.; Marina Benaur, B.S.; Melissa Lewandowski, B.S.; Molly Fortner, B.S.
Depression and Anxiety Symptoms in Women at High Risk for Breast Cancer: Pilot Study of a Group Intervention
David K. Wellisch, Ph.D.; Alisa Hoffman, Ph.D.; Sherry Goldman, R.N., N.P.; Jennifer Hammerstein, R.D.; Karen Klein, Ph.D.; Michele Bell, M.A.
Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia
Caleb M. Adler, M.D.; Anil K. Malhotra, M.D.; Igor Elman, M.D.; Terry Goldberg, Ph.D.; Michael Egan, M.D.; David Pickar, M.D.; Alan Breier, M.D.
Obstetrical Complications and Childhood-Onset Schizophrenia
Rob Nicolson, M.D.; Dolores Malaspina, M.D.; Jay N. Giedd, M.D.; Susan Hamburger, M.A.; Marge Lenane, L.C.S.W.; Jeffrey Bedwell, B.S.; Tom Fernandez, A.B.; Ariela Berman, B.S.; Ezra Susser, Ph.D.; Judith L. Rapoport, M.D.
Olanzapine-Induced Tardive Dystonia
EDUARDO DUNAYEVICH, M.D.; STEPHEN M. STRAKOWSKI, M.D.
Pain: Cause of Agitation in Elderly Individuals With Dementia
YONAS ENDALE GEDA, M.D.; TERESA A. RUMMANS, M.D.
Clozapine-Induced Stuttering: Epileptic Brain Activity?
TILLMANN SUPPRIAN, M.D.; WOLFGANG RETZ, M.D.; JÜRGEN DECKERT, M.D.
Attention Deficit Hyperactivity Disorder in the Prison Population
STEPHEN CURRAN, M.B, M.R.C.PSYCH.; MICHAEL FITZGERALD, M.D., M.R.C.PSYCH.
Sildenafil for Sexual Dysfunction in Women Taking Antidepressants
H. GEORGE NURNBERG, M.D.; JOHN LAURIELLO, M.D.; PAULA L. HENSLEY, M.D.; LYNDA M. PARKER, M.D.; SAMUEL J. KEITH, M.D.
Dr. Goldstein and Colleagues Reply
JILL M. GOLDSTEIN, PH.D.; LARRY J. SEIDMAN, PH.D.; MING T. TSUANG, M.D., PH.D.
Neuropsychological Functions in Patients With Schizophrenia
MARGOT ALBUS, M.D., PH.D.; WERNER HUBMANN, M.D.